KLRA
Kailera Therapeutics, Inc. Common Stock
NASDAQ: KLRA · HEALTHCARE · BIOTECHNOLOGY
$25.15
+0.60% today
Updated 2026-05-01
Market cap
$3.21B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.26
Dividend yield
—
52W range
$16 – $28
Volume
1.8M
Kailera Therapeutics, Inc. Common Stock (KLRA) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-36.90%
ROA
-22.70%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2025 | $0.00 | $-148.96M | — | — | — |